Product Overview

1cP-LSD 150mcg Art Blotters represent a premium, brandless formulation of high-purity (≥98%) lysergamide reference standard delivered through artistically designed blotter substrates specifically engineered for professional analytical chemistry laboratories and forensic research facilities. As a structurally modified analogue within the lysergamide chemical class—featuring cyclopropionyl substitution at the indole nitrogen position—this compound maintains direct structural kinship with lysergic acid diethylamide while providing distinct chromatographic and mass spectrometric signatures essential for method validation, reference library construction, and qualitative/quantitative assay development across diverse research applications.

The 150mcg nominal content per individual blotter ensures exceptional dose uniformity across production sheets, enabling researchers to execute highly reproducible calibration curves, proficiency testing panels, and inter-laboratory comparative studies with minimal variability between replicates or batches. Artistically patterned blotter designs serve purely functional laboratory identification purposes, facilitating visual batch differentiation during inventory management, experimental tracking, and quality assurance documentation without influencing the embedded analyte’s chemical integrity or analytical performance characteristics.

Manufacturing processes employ pharmaceutical-grade excipient matrices optimized for analyte stability, uniform impregnation, and controlled extraction efficiency when interfacing with liquid chromatography-mass spectrometry (LC-MS), gas chromatography-mass spectrometry (GC-MS), or high-performance liquid chromatography (HPLC) systems commonly deployed in research laboratories. This product exists solely for institutional and professional research contexts where investigators possess requisite training, infrastructure, and regulatory authorizations for handling Schedule I analogue substances under controlled laboratory conditions. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Chemical Identity & Classification

1cP-LSD bears the systematic IUPAC designation (6aR,9R)-N,N-diethyl-7-(cyclopropanecarbonyl)-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide, commonly referenced in analytical literature as 1-cyclopropionyl-lysergic acid diethylamide or 1-CPA-LSD. Additional synonyms encompass 1-cyclopropanecarbonyl-LSD and cyclopropionyl-LSD, positioning this entity within the substituted lysergamide subclass alongside related N-acyl derivatives developed for forensic standard applications. The compound appears in certified reference material catalogs from commercial suppliers and international forensic databases, underscoring its established role in analytical method validation rather than any form of applied administration.

Core molecular formula registers as C24H29N3O2 for the freebase species, yielding precise molecular weight 391.51 g/mol with empirical formula mass confirmed via high-resolution mass spectrometry in research publications. When supplied as hemi-L-tartrate salt (as documented in select specifications), formulation shifts to C26H31N3O2- 0.5C4H6O6 with corresponding mass adjustment to approximately 466.4 g/mol, though freebase equivalence maintains analytical consistency across platforms. Canonical SMILES notation CCN(CC)C(=O)[C@H]1CN(C)[C@@H]2Cc3cn(C(=O)C4CC4)c5ccccc5c3C2=C1 and InChI=1S/C24H29N3O2/c1-3-27(4-2)24(29)17-10-12-26(5)21(13-17)20-14-18-16-8-6-7-9-19(16)25(23(20)22(18)15-26)11-28/h6-9,14,21H,3-5,10-13,15H2,1-2H3/t21-,26-/m1/s1 facilitates unambiguous structural database matching essential for library searching and automated identification workflows.

CAS registry number 2767597-50-0 provides universal chemical identification across global standards organizations, regulatory filings, and commercial reference inventories. Classification schemes consistently categorize 1cP-LSD as a new psychoactive substance (NPS) lysergamide analogue specifically within analytical toxicology and forensic chemistry domains, excluding any biomedical or therapeutic context.

Chemical & Physical Characteristics

Art blotter presentation embeds 1cP-LSD freebase or salt within specialized absorbent cellulosic substrates precision-perforated into discrete 150mcg dosage units, yielding compact, visually distinctive sheets suitable for archival storage, serial sampling, and direct instrumental analysis following solvent extraction. Substrate composition incorporates inert binders ensuring quantitative analyte recovery during methanol, acetonitrile, or aqueous-organic mobile phase extraction while resisting matrix interference in electrospray ionization or atmospheric pressure chemical ionization interfaces.

Physical manifestation typically includes intricate artistic motifs—fractal geometries, symbolic iconography, or abstract patterns—serving laboratory batch coding functions through unique visual signatures that streamline inventory segregation, experimental provenance tracking, and quality control reconciliation without compromising chemical stability or extraction kinetics. Colorimetric properties derive from non-reactive cellulosic dyes or pigments pharmacologically inert to the active lysergamide, maintaining spectral neutrality across ultraviolet-visible (UV-Vis) detection wavelengths employed in HPLC monitoring.

Solubility profile exhibits high affinity for polar protic solvents (methanol > ethanol) and aprotic organics (acetonitrile, dimethyl sulfoxide), supporting diverse LC gradient elution strategies from reversed-phase C18 to hydrophilic interaction liquid chromatography (HILIC) modalities. Thermal decomposition initiates above 180°C under inert atmosphere, aligning with fast GC applications when derivatization proves unnecessary due to inherent volatility of the underivatized freebase. Photochemical lability to ultraviolet A/B radiation necessitates amberized or foil-laminated secondary containment during prolonged storage, mirroring classical lysergamide susceptibilities documented across decades of analytical literature.

Purity & Analytical Verification

Manufacturing specifications mandate minimum ≥98% w/w purity versus reference standard, independently verified through orthogonal analytical suites comprising reversed-phase HPLC-UV/DAD at multiple wavelengths (220, 254, 280 nm), electron impact GC-MS with full-scan and selected ion monitoring acquisition, quantitative 1H/13C NMR spectroscopy with internal standard integration, and ultra-high-performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS) employing multiple reaction monitoring transitions. These methodologies collectively resolve potential synthesis-derived impurities including desacyl-LSD, iso-LSD epimers, N-demethyl metabolites, cyclopropanecarboxylic acid residuals, and diethylamide hydrolysis fragments, establishing comprehensive impurity profiles below 0.5% relative to main peak area.

Residual solvent analysis per ICH Q3C guidelines limits Class 1 solvents (benzene, toluene) to <2 ppm via headspace GC, while heavy metals screening adheres to USP <232> thresholds through inductively coupled plasma mass spectrometry (ICP-MS). Microbiological enumeration confirms sterility suitable for cleanroom manipulation, absent endotoxins per LAL chromogenic assay. Comprehensive Certificates of Analysis (COAs) enumerate all quantitative results with method validation parameters (linearity r²>0.999, LOD/LOQ, precision RSD<2%), chromatograms, and NMR spectra, enabling seamless integration into laboratory quality management systems and accreditation dossiers.

Quality Control & Batch Integrity

Batch production initiates with lot-specific synthesis under current Good Manufacturing Practice (cGMP)-analogous controls, assigning immutable alphanumeric identifiers traceable through enterprise resource planning systems from raw material CoAs to final release disposition. In-process controls encompass real-time HPLC reaction monitoring, thin-layer chromatography (TLC) purity checkpoints, and Karl Fischer water determination, culminating in 100% blotter sheet visual inspection coupled with automated content uniformity assessment via punch-dissolution UV assay across 10-20 units per sheet.

Retain samples preserved under identical storage simulates support 24-month stability demonstration through accelerated (40°C/75% RH) and real-time protocols, confirming 150mcg assay retention >98% with impurity growth <0.2%. Third-party ISO 17025-accredited laboratory audits provide independent verification of identity (HRMS accurate mass ±0.5 ppm), potency (±5% RSD), and release criteria compliance, bolstering chain-of-custody documentation essential for multi-site collaborations, proficiency schemes, and regulatory inspections. Integrated documentation packages facilitate electronic batch record (EBR) archiving and audit trail reconstruction spanning seven years minimum.

Safety, Handling & Laboratory Precautions

Exclusive manipulation demands Class II biosafety cabinet or chemical fume hood operation by personnel holding documented training in DEA Schedule I analogue protocols, attired in layered personal protective equipment ensembles comprising powder-free nitrile gloves (8 mil minimum), ANSI Z87.1 chemical splash goggles, flame-resistant laboratory coats, and closed-toe footwear. Engineering controls include high-efficiency particulate air (HEPA) filtration, negative pressure ventilation (>100 linear feet per minute face velocity), and secondary spill containment trays lined with 40% sorbency chemical neutralizer pads.

Administrative controls mandate standard operating procedures governing receipt verification, segregation storage, witnessed aliquoting, waste segregation (as hazardous non-acute per RCRA D001 ignitability characteristic), and incident reporting per OSHA 29 CFR 1910.1450 laboratory standard. Safety Data Sheets (SDS) formatted per GHS Revision 9 delineate physical hazards (flammable solid Category 2 if aerosolized), environmental precautions (aquatic acute 3/chronic 3), and incompatible materials (strong oxidizers, mineral acids) alongside first-aid measures and physician notification language—exclusive of toxicological data interpretations.

Packaging, Labeling & Storage

Primary containment utilizes precision-perforated, vacuum-desiccated blotter sheets (100-1000 units) sandwiched between polyethylene terephthalate (PET) / aluminum foil / polyethylene laminate barriers achieving moisture vapor transmission rates <0.01 g/m²/day and oxygen transmission <0.5 cc/m²/day. Secondary child-resistant, tamper-evident high-density polyethylene (HDPE) bottles incorporate pressure-equalization valves and desiccative silica gel sachets maintaining <10% relative humidity equilibrium.

Globally Harmonized System (GHS) labeling integrates product nomenclature, CAS identifier, net blotter count × 150mcg potency declaration, batch/lot code with manufacture/expiry dating, DOT/ADR/IATA hazard class 9 “miscellaneous dangerous goods” diamond, and NFPA 704 hazard ratings (Health 2, Flammability 1, Reactivity 0, Special K). Recommended storage prescribes -20°C ±5°C freezer compartments under light-excluding conditions, prohibiting freeze-thaw excursions beyond 12-hour transit tolerances and mandating 24-hour equilibration to ambient prior to extraction to mitigate condensation-induced hydrolysis.

Intended Research Use & Market Positioning

1cP-LSD 150mcg Art Blotters target analytical toxicology laboratories, forensic casework facilities, pharmaceutical counterfeiting investigations, and academic structure-activity investigations within the lysergamide pharmacophore space. Core applications encompass UHPLC-MS/MS screening method optimization (LOD 0.1-1 ng/mL whole blood equivalents), GC-MS confirmation workflows incorporating electron impact (EI) library matching (base peaks m/z 225, 208, 293), reference material certification for external quality assessment schemes, and impurity profiling distinguishing positional N1-acyl regioisomers via NMR J-coupling analysis.

High-purity, lot-traceable presentation positions this material as institutional-grade standard bridging commercial reference suppliers and in-house synthesis, eliminating reformulation uncertainties while supporting Good Laboratory Practice (GLP) documentation hierarchies. Multi-disciplinary utility spans environmental monitoring of NPS in wastewater effluents, workplace drug testing false-positive adjudication, and clandestine laboratory reconstruction through comparative microspectroscopy of seized blotter exemplars.

Ordering, Availability & Fulfillment

Catalog positioning ensures immediate availability through tiered institutional procurement channels incorporating Just-In-Time (JIT) inventory feeds, verified purchaser account protocols, and electronic data interchange (EDI) purchase order processing compliant with 21 CFR Part 11 electronic signatures. Batch-specific selection interfaces display real-time stock status, projected expiry, and COA hyperlinks, streamlining laboratory reorder cycles while capturing chain-of-custody metadata.

Fulfillment deploys temperature-controlled logistics (2-8°C 96-hour hold) via validated carriers providing end-to-end GPS tracking, electronic proof-of-delivery, and reconciliation against shipping manifests. Comprehensive support encompasses 24/7 documentation portals hosting SDS/COA downloads, technical query resolution via PhD-level application specialists, and compliance consultation for international import permit navigation.​

Legal & Regulatory Disclaimer

1cP-LSD 150mcg Art Blotters supply exclusively constitutes laboratory research chemical absent authorization, labeling, or positioning for human consumption, veterinary administration, clinical diagnostics, therapeutic intervention, or any biological matrix application whatsoever. Purchaser assumes complete responsibility for verifying jurisdictional scheduling under United Nations Convention on Psychotropic Substances analogues, national controlled substances acts, and institutional research ethics board approvals prior to acquisition.

Material transfer presumes recipient affirmation of lawful research intent by credentialed investigators within permitted facilities, prohibiting resale, diversion, or transshipment toward unlicensed end-users. Regulatory status exhibits analogue scheduling evolution across jurisdictions—consult primary legal sources rather than vendor representations. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.